Old Web
English
Sign In
Acemap
>
Paper
>
Impact of Landmark Responses on 3-Year Outcomes in CP-CML Patients in the Ponatinib PACE Trial
Impact of Landmark Responses on 3-Year Outcomes in CP-CML Patients in the Ponatinib PACE Trial
2016
Moshe Talpaz
Martin C. Müller
Michele Baccarani
Michael W. Deininger
François Guilhot
Andreas Hochhaus
Timothy P. Hughes
Neil P. Shah
Stephanie Lustgarten
Victor M. Rivera
Tim Clackson
Frank G. Haluska
Jorge E. Cortes
Keywords:
Ponatinib
Physical therapy
Medicine
Pace
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]